Literature DB >> 30985410

A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.

Hongyan Yin1, Yan Hu1, Yan Xiu1, Rongkui Luo2, Hongcheng Shi1.   

Abstract

Primary endometrial hepatoid adenocarcinoma is a rare tumor. We present a case of a 64-year-old woman with vaginal bleeding for 2 months and a markedly elevated serum α-fetoprotein of 3931 ng/mL. Hysteroscopic segmental curettage revealed endometrial adenocarcinoma. A pelvic MRI was performed for local tumor invasion, which showed only endometrial mass. An abdominal enhanced CT showed no liver lesion, which excluded primary hepatic carcinoma. Staging F-FDG PET/CT demonstrated a hypermetabolic mass in the endometrium. A total hysterectomy with bilateral salpingo-oophorectomy and regional lymphadenectomy were performed. Postoperatively, the mass was diagnosed as primary endometrial hepatoid adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30985410     DOI: 10.1097/RLU.0000000000002538

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Disseminated Primary Uterine Hepatoid Adenocarcinoma with α-Fetoprotein Production Demonstrated on 18F-FDG PET/CT.

Authors:  Danijela Dejanovic; Marie Boennelycke; Annemarie Gjelstrup Amtoft; Charlotte Birk Christensen; Victoria Wetterstroem; Annika Loft; Trine Jakobi Noettrup
Journal:  Diagnostics (Basel)       Date:  2022-06-12

2.  Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review.

Authors:  Zhitao Chen; Chenchen Ding; Ting Zhang; Yahui He; Guoping Jiang
Journal:  Onco Targets Ther       Date:  2022-06-01       Impact factor: 4.345

3.  α-Fetoprotein-Producing Endometrial Carcinoma Is Associated With Fetal Gut-Like and/or Hepatoid Morphology, Lymphovascular Infiltration, TP53 Abnormalities, and Poor Prognosis: Five Cases and Literature Review.

Authors:  Tomoyuki Otani; Kosuke Murakami; Naoki Shiraishi; Man Hagiyama; Takao Satou; Mitsuru Matsuki; Noriomi Matsumura; Akihiko Ito
Journal:  Front Med (Lausanne)       Date:  2021-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.